share_log

新銳醫藥：(1)建議授出發行新股份及購回股份之一般授權； (2)建議重選退任董事； 及 (3)股東週年大會通告

NEW RAY MEDIC: (1) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE NEW SHARES AND TO REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; AND (3) NOTICE OF ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  Apr 24 08:31
Summary by Moomoo AI
新銳醫藥國際控股有限公司（新銳醫藥）將於2024年6月18日舉行股東週年大會，會上將提出發行新股份及購回股份的一般授權，以及重選退任董事的建議。該公司股東先前於2023年6月15日的股東週年大會上授予的董事發行及購回股份的一般授權將於本次大會結束時屆滿。為保持公司靈活性，將提議向董事授出新的一般授權，允許發行不超過已發行股份總數20%的股份，並購回不超過10%的股份。此外，王秋勤女士、褚雪平先生及梁志堅先生將退任並符合資格重選。股東週年大會的通告已於公司網站及聯交所網站公布，並提醒股東於2024年6月16日或之前提交代表委任表格。公司亦將於2024年6月13日至6月18日暫停股份過戶登記。
新銳醫藥國際控股有限公司（新銳醫藥）將於2024年6月18日舉行股東週年大會，會上將提出發行新股份及購回股份的一般授權，以及重選退任董事的建議。該公司股東先前於2023年6月15日的股東週年大會上授予的董事發行及購回股份的一般授權將於本次大會結束時屆滿。為保持公司靈活性，將提議向董事授出新的一般授權，允許發行不超過已發行股份總數20%的股份，並購回不超過10%的股份。此外，王秋勤女士、褚雪平先生及梁志堅先生將退任並符合資格重選。股東週年大會的通告已於公司網站及聯交所網站公布，並提醒股東於2024年6月16日或之前提交代表委任表格。公司亦將於2024年6月13日至6月18日暫停股份過戶登記。
NUROI PHARMACEUTICALS INTERNATIONAL HOLDINGS LIMITED (NUROI PHARMACEUTICALS) WILL HOLD ITS ANNUAL GENERAL MEETING ON 18 JUNE 2024 AT WHICH GENERAL MANDATES TO ISSUE NEW SHARES AND REPURCHASE SHARES WILL BE PROPOSED, AS WELL AS A PROPOSAL TO RE-ELECT RETIRING DIRECTORS. THE GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES PREVIOUSLY GRANTED BY THE COMPANY'S SHAREHOLDERS AT THE ANNUAL GENERAL MEETING ON JUNE 15, 2023 WILL EXPIRE AT THE CLOSE OF THIS MEETING. In order to maintain the company's flexibility, it is proposed to grant the directors a new general mandate allowing the issuance of no more than 20% of the total issued shares and the repurchase of no more than 10% of the shares. In addition, Ms. WANG Qiu Qin, Mr. Yue Ping and...Show More
NUROI PHARMACEUTICALS INTERNATIONAL HOLDINGS LIMITED (NUROI PHARMACEUTICALS) WILL HOLD ITS ANNUAL GENERAL MEETING ON 18 JUNE 2024 AT WHICH GENERAL MANDATES TO ISSUE NEW SHARES AND REPURCHASE SHARES WILL BE PROPOSED, AS WELL AS A PROPOSAL TO RE-ELECT RETIRING DIRECTORS. THE GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES PREVIOUSLY GRANTED BY THE COMPANY'S SHAREHOLDERS AT THE ANNUAL GENERAL MEETING ON JUNE 15, 2023 WILL EXPIRE AT THE CLOSE OF THIS MEETING. In order to maintain the company's flexibility, it is proposed to grant the directors a new general mandate allowing the issuance of no more than 20% of the total issued shares and the repurchase of no more than 10% of the shares. In addition, Ms. WANG Qiu Qin, Mr. Yue Ping and Mr. Leung Chi Kin will retire and be eligible for re-election. THE NOTICE OF THE ANNUAL GENERAL MEETING HAS BEEN PUBLISHED ON THE COMPANY'S WEBSITE AND THE EXCHANGE WEBSITE AND REMINDS SHAREHOLDERS TO SUBMIT THE PROXY FORM ON OR BEFORE 16 JUNE 2024. The Company will also suspend the registration of shares from 13 June to 18 June 2024.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more